Data / Form D filings / NEURALTUS PHARMACEUTICALS, INC.
NEURALTUS PHARMACEUTICALS, INC.: Form D filings
NEURALTUS PHARMACEUTICALS, INC., a pharmaceuticals company in San Bruno, CA, filed 4 Form D notices with the SEC between 2009 and 2016. The latest, on May 24, 2016, reports $14.9 million sold of a $21.9 million offering to 4 investors.
Find out what NEURALTUS PHARMACEUTICALS, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1001 BAYHILL DRIVE, SUITE 300, San Bruno, CA, 94066
- Phone
- (650) 424-1600
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1459308
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 24, 2016 | New notice | $21,938,357 | $14,938,357 | $7,000,000 | 4 | May 17, 2016 | sec.gov |
| May 31, 2012 | Amendment | $11,125,649 | $11,125,649 | $0 | 22 | Dec 15, 2011 | sec.gov |
| Dec 20, 2011 | New notice | $11,125,536 | $9,625,431 | $1,500,105 | 7 | Dec 15, 2011 | sec.gov |
| Apr 7, 2009 | New notice | $18,000,000 | $4,893,853 | $13,106,147 | 6 | Mar 25, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James Woody | Director | |
| Donald McGovern | Director | |
| Annette Bianchi | Director | |
| John Whelan | Executive Officer | |
| Richard Casey | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of May 23, 2016 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NEURALTUS PHARMACEUTICALS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.